首页> 外文期刊>JAMA: the Journal of the American Medical Association >Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group (see comments) (published erratum appears in
【24h】

Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group (see comments) (published erratum appears in

机译:老年人高血压治疗中的钠减少和体重减轻:老年人非药物干预的随机对照试验(TONE)。通力合作研究小组(见评论)(发表的勘误出现在

获取原文
获取原文并翻译 | 示例
       

摘要

CONTEXT: Nonpharmacologic interventions are frequently recommended for treatment of hypertension in the elderly, but there is a paucity of evidence from randomized controlled trials in support of this recommendation. OBJECTIVE: To determine whether weight loss or reduced sodium intake is effective in the treatment of older persons with hypertension. DESIGN: Randomized controlled trial. PARTICIPANTS: A total of 975 [corrected] men and women aged 60 to 80 years with systolic blood pressure lower than 145 mm Hg and diastolic blood pressure lower than 85 mm Hg while receiving treatment with a single antihypertensive medication. SETTING: Four academic health centers. INTERVENTION: The 585 obese participants were randomized to reduced sodium intake, weight loss, both, or usual care, and the 390 nonobese participants were randomized to reduced sodium intake or usual care. Withdrawal of antihypertensive medication was attempted after 3 months of intervention. MAIN OUTCOME MEASURE: Diagnosis of high blood pressure at 1 or more follow-up visits, or treatment with antihypertensive medication, or a cardiovascular event during follow-up (range, 15-36 months; median, 29 months). RESULTS: The combined outcome measure was less frequent among those assigned vs not assigned to reduced sodium intake (relative hazard ratio, 0.69; 95% confidence interval [CI], 0.59-0.81; P<.001) and, in obese participants, among those assigned vs not assigned to weight loss (relative hazard ratio, 0.70; 95% CI, 0.57-0.87; P<.001). Relative to usual care, hazard ratios among the obese participants were 0.60 (95% CI, 0.45-0.80; P<.001) for reduced sodium intake alone, 0.64 (95% CI, 0.49-0.85; P=.002) for weight loss alone, and 0.47 (95% CI, 0.35-0.64; P<.001) for reduced sodium intake and weight loss combined. The frequency of cardiovascular events during follow-up was similar in each of the 6 treatment groups. CONCLUSION: Reduced sodium intake and weight loss constitute a feasible, effective, and safe nonpharmacologic therapy of hypertension in older persons.
机译:语境:经常推荐使用非药物干预措施来治疗老年人高血压,但是随机对照试验缺乏证据支持这一建议。目的:确定体重减轻或钠摄入减少对老年人高血压的治疗是否有效。设计:随机对照试验。参加者:总共975名年龄在60至80岁之间的[校正]男性和女性在接受单一降压药治疗的同时收缩压低于145 mm Hg,舒张压低于85 mm Hg。地点:四个学术保健中心。干预:585名肥胖参与者被随机分配以减少钠摄入量,减轻体重,两者或常规护理,而390名非肥胖参与者被随机分配以减少钠摄入量或常规护理。干预3个月后尝试停用降压药。主要观察指标:在1次或更多次随访,诊断为抗高血压药物治疗或随访期间发生心血管事件(范围15-36个月;中位数29个月)时诊断出高血压。结果:联合结果测量在分配钠盐摄入量减少和未分配钠盐摄入量减少之间的频率相对较低(相对危险度,0.69; 95%置信区间[CI],0.59-0.81; P <.001),在肥胖参与者中体重减轻与未体重减轻之间的相关性(相对危险比,0.70; 95%CI,0.57-0.87; P <.001)。相对于常规护理,肥胖参与者的危险比为:钠摄入量减少时为0.60(95%CI,0.45-0.80; P <.001),体重为0.64(95%CI,0.49-0.85; P = .002)单独减少体重,和0.47(95%CI,0.35-0.64; P <.001)用于减少钠摄入量和减轻体重。在六个治疗组中,随访期间心血管事件的发生频率相似。结论:减少钠摄入量和减轻体重是老年人高血压的一种可行,有效和安全的非药物治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号